Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Maze Therapeutics Inc.

    NASDAQ: MAZE · Real-Time Price · USD
    13.49
    0.14 (1.05%)
    At close: Aug 15, 2025, 3:59 PM
    13.50
    0.07%
    After-hours: Aug 15, 2025, 05:38 PM EDT

    Maze Therapeutics Income Statement

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
    Revenue
    		 n/a n/a n/a 2.5M 165M n/a n/a n/a
    Cost of Revenue
    		 649K 684K 705K 788K n/a 950K 976K 1M
    Gross Profit
    		 -649K -684K -705K 2.5M 165M -950K -976K -1M
    Operating Income
    		 -36.47M -35.4M -29.73M -24.23M 139.56M -28.01M -23.05M -25.23M
    Interest Income
    		 n/a 2.62M 1.52M 1.85M 1.01M 281K 304K 481K
    Pretax Income
    		 -33.68M -32.79M -29.85M -25.03M 140.78M -32.49M -26.58M -24.75M
    Net Income
    		 -33.68M -32.79M -29.58M -24.75M 139.06M -32.49M -26.58M -24.75M
    Selling & General & Admin
    		 8.37M 7.82M 7.51M 6.87M 5.9M 6.14M 7.01M 5.77M
    Research & Development
    		 28.11M 27.58M 22.22M 19.86M 19.55M 21.88M 16.05M 19.46M
    Other Expenses
    		 -649K -684K n/a n/a n/a n/a n/a n/a
    Operating Expenses
    		 35.83M 34.72M 29.73M 26.73M 25.45M 28.01M 23.05M 25.23M
    Interest Expense
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 36.47M 35.4M 29.73M 26.73M 25.45M 28.01M 23.05M 25.23M
    Income Tax Expense
    		 n/a n/a -275K -279K 1.73M n/a n/a n/a
    Shares Outstanding (Basic)
    		 43.85M 43.8M 43.8M 43.78M 43.79M 43.8M 43.78M 43.78M
    Shares Outstanding (Diluted)
    		 43.85M 43.8M 43.8M 43.78M 43.79M 43.8M 43.78M 43.78M
    EPS (Basic)
    		 -0.77 -0.75 -0.11 -0.06 0.98 -0.74 -0.61 -0.57
    EPS (Diluted)
    		 -0.77 -0.75 -0.11 -0.06 0.98 -0.74 -0.61 -0.57
    EBITDA
    		 -36.47M -35.4M -29.02M -23.44M 140.41M -27.06M -22.07M -24.22M
    EBIT
    		 -33.68M -32.79M -29.73M -24.23M 139.56M -28.01M -23.05M -25.23M
    Depreciation & Amortization
    		 n/a 684K 705K 788K 854K 950K 976K 1M

    Add to Watchlist